ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Bioorganic & Medicinal Chemistry Letters
Volume 16, Issue 6, 15 March 2006, Pages 1527-1531
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (144 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmcl.2005.12.038    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier Ltd All rights reserved.

Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors

Guan-Sheng Jiaoa, Corresponding Author Contact Information, E-mail The Corresponding Author, Lynne Cregarb, Mark E. Goldmanb, , Sherri Z. Millisb and Cho Tanga,

aDepartment of Chemistry, Hawaii Biotech, Inc., 99-193 Aiea Heights Dr., Suite 200, Aiea, HI 96701, USA bDepartment of Lead Discovery, Hawaii Biotech, Inc., 99-193 Aiea Heights Dr., Suite 200, Aiea, HI 96701, USA

Received 29 October 2005; 
revised 9 December 2005; 
accepted 9 December 2005. 
Available online 4 January 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Anthrax lethal factor is a Zn2+-dependent metalloprotease and the key virulence factor of tripartite anthrax toxin secreted by Bacillus anthracis, the causative agent of anthrax. A series of guanidinylated 2,5-dideoxystreptamine derivatives were designed and synthesized as inhibitors of lethal factor, some of which show strong inhibitory activity against lethal factor in an in vitro FRET assay. Preparation and structure–activity relationships of these compounds are presented.

Graphical abstract

Anthrax lethal factor is a Zn2+-dependent metalloprotease and the key virulence factor of tripartite anthrax toxin secreted by Bacillus anthracis, the causative agent of anthrax. A series of guanidinylated 2,5-dideoxystreptamine derivatives were designed and synthesized as inhibitors of lethal factor, some of which show strong inhibitory activity against lethal factor in an in vitro FRET assay. Preparation and structure–activity relationships of these compounds are presented.


Keywords: Lethal factor inhibitors; Anthrax; Metalloprotease; Guanidinylated 2,5-dideoxystreptamine derivatives

Article Outline

Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.